XML 319 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net revenues
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenues
The following table disaggregates revenue by global product category for the years ended December 31, 2023, 2022 and 2021.
Year Ended December 31,
202320222021
Vascular access$708,044 $683,612 $700,240 
Anesthesia389,957 388,890 380,140 
Interventional511,434 445,018 427,500 
Surgical427,359 392,917 377,756 
Interventional urology319,785 322,832 341,661 
OEM326,008 272,624 245,681 
Other (1)
291,902 285,148 336,585 
Net revenues (2)
$2,974,489 $2,791,041 $2,809,563 
(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture.
(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments includes net revenues from each of the non-OEM product categories listed above.